Composition
- Active ingredients
- SULFACETAMIDE SODIUM 30%
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA080028.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Bleph-30
- Active substance
- sulfacetamide sodium
- Route
- Eye
- Dosage form
- Solution/drops
- Applicant
- Allergan
- Status
- Discontinued
- FDA approval
- 25 May 1971
- Application
- ANDA080028-002